A5015365060- Acute Myocardial Infarction Research
- Optical Coherence Tomography Applications
- Congenital Diaphragmatic Hernia Studies
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Neuroscience of respiration and sleep
- Ocular Oncology and Treatments
- Cutaneous Melanoma Detection and Management
- Neonatal Respiratory Health Research
Østfold Hospital Trust
2017-2020
Jagiellonian University
2015
Neuroblastoma (NB), Hirschsprung disease (HSCR), Congenital Central Hypoventilation Syndrome (CCHS), clinically referred as the NB-HSCR-CCHS cluster, are genetic disorders linked to mutations in PHOX2B gene on chromosome 4p12.The specific aim of this project is define genomic basis for clinical manifestations cluster.A one day old male patient presented Jagiellonian University Medical College (JUMC), American Children Hospital, neonatal Intensive Care Unit (ICU) due abdominal distention,...
Background Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation VTE in efficacy and safety. Increased fatigue after initiation has been observed clinical practice, but data on this potential side effect are lacking. Objective The study aimed evaluate development patients treated VTE, comparing other anticoagulants. Methods Patients were prospectively...